Navigation Links
Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms
Date:3/31/2008

ID-TLR) rates were comparable, at 3.8 percent for the XIENCE V (PROMUS) Stent and 6.8 percent for the TAXUS Stent (p=0.33). Major adverse cardiac events (MACE) rates comprised of cardiac death, all MI and ID-TLR were also comparable, at 6.6 percent for the XIENCE V (PROMUS) Stent and 11.0 percent for the TAXUS Stent (p=0.31).

Stent thrombosis rates at two years using the Academic Research Consortium (ARC) definite/probable definition were low for both the XIENCE V (PROMUS) Stent (0.9%) and the TAXUS Stent (1.4%). Angiographic outcomes showed numerically equivalent late loss, with 0.33 mm for XIENCE V (PROMUS) and 0.34 mm for TAXUS (p=0.60). In-stent binary restenosis rates at two years were also comparable for the XIENCE V (PROMUS) Stent and the TAXUS Stent (2.1% vs. 2.9%, p=1.0).

"Boston Scientific's two DES platforms - the TAXUS and PROMUS Stents - both performed extremely well in the SPIRIT II Trial out to two years," said Paul LaViolette, Chief Operating Officer of Boston Scientific. "The data, once again, demonstrated impressive safety and efficacy profiles with low stent thrombosis rates and similar clinical outcomes. We look forward to future data from the SPIRIT Clinical Trial Program as well as from our PROENCY Registries in Europe and the United States - the first to observe different 'Olimus-eluting coronary stents in a real-world setting."

In February, Boston Scientific announced that the first patient had been enrolled in its PROENCY (PROMUS(TM), ENdeavor(R) and CYpher(R)) European Registry. The registry will collect real-life clinical outcome data for the PROMUS Stent and compare them with data from Johnson & Johnson's Cypher(R) Sirolimus-Eluting Stent and Medtronic's Endeavor(R) Zotarolimus-Eluting Stent in patients in routine clinical practice. A U.S. PROENCY Registry is expected to begin enrolling patients in July and complete enrollment by the end of 2008.

The XIENCE(TM) V (PROMUS) Stent is currently pending approval by
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
2. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
3. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
4. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
5. Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
6. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
7. BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM)
8. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
9. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
10. Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously
11. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... CHAPEL HILL, N.C. , Sept. 4, 2015 ... Science Liaisons (MSLs) and other Field-Based Medical Specialists ... physicians, key opinion leaders, and thought leaders in ... the effectiveness of their field-based teams, companies are ... in order to align countries with corporate objectives ...
(Date:9/4/2015)... 4, 2015  Essilor is pleased to announce the ... against the eyestrain that comes with the constant connection ... as an everyday pair of glasses to provide comfort ... on smart phones, tablets and computers for hours at ... require a prescription but also those who currently wear ...
(Date:9/4/2015)... 2015  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... Wells Fargo Securities 2015 Healthcare Conference in Boston ... th at 2:30 p.m. Eastern Time. To listen to ... visit the Investors section of the Company,s Web site at ... days after the event.  Orexigen Contact: , ...
Breaking Medicine Technology:New Study Presents Tactics and Insights on How to Effectively Globalize Medical Science Liaison Programs in the Pharmaceutical Industry 2Essilor Launches New Eyezen Glasses Specifically Designed For A Digital Focused Audience 2
... July 21, 2011 BioMedix™, a leader in providing ... been awarded a U.S. Patent recognizing its innovative solutions ... On July 19, 2011, the United States ... entitled "System and Method for Testing for Cardiovascular Disease," ...
... IRVINE, Calif., July 21, 2011 Endologix, Inc. (NASDAQ: ... aortic disorders, today announced financial results for the three and ... Endologix President and Chief Executive Officer, said, "We are pleased ... to achieve our growth and new product development goals for ...
Cached Medicine Technology:BioMedix™ Receives Patent for Its Innovative Collaborative Care Business Method 2Endologix Reports 22% Second Quarter 2011 Revenue Growth 2Endologix Reports 22% Second Quarter 2011 Revenue Growth 3Endologix Reports 22% Second Quarter 2011 Revenue Growth 4Endologix Reports 22% Second Quarter 2011 Revenue Growth 5Endologix Reports 22% Second Quarter 2011 Revenue Growth 6Endologix Reports 22% Second Quarter 2011 Revenue Growth 7Endologix Reports 22% Second Quarter 2011 Revenue Growth 8Endologix Reports 22% Second Quarter 2011 Revenue Growth 9
(Date:9/4/2015)... ... 2015 , ... According to an article published August 4th by ... data showing that it is safe for pregnant women to undergo local anesthesia needed ... local anesthesia with a group that hadn’t, researchers were able to determine that “local ...
(Date:9/4/2015)... California (PRWEB) , ... September 04, 2015 , ... The ... behalf of Tanya De La Paz. , Schmidt National Law Group, a leading ... Northern District of California against Bayer Corp., Bayer Essure, Inc., and other Bayer affiliates ...
(Date:9/4/2015)... GA (PRWEB) , ... September 04, 2015 , ... After ... is in desperate need of new apparel. In an effort to assist the team, ... Marietta, has launched a charity drive to raise funds for the new uniforms. , ...
(Date:9/4/2015)... ... September 04, 2015 , ... Keeping mold top of ... the home is quite common. Mold can grow anywhere - on carpet, clothing, food, ... Checking for excessive moisture and water in the home is key to preventing mold ...
(Date:9/4/2015)... ... ... are looking for a quick and convenient way to produce a hot remedy for colds. ... a quick and simple way to brew a hot cup of cold remedy when desired. ... they enhance comfort and health. The invention features a novel design that is lightweight, compact ...
Breaking Medicine News(10 mins):Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2
... strike of Maharastra Doctors. The healthcare services continues to ... instances.// The government today took a firm stand and ... ,Currently with this decision over 350 doctors ... doctors from 15 government-managed hospitals have stayed away from ...
... detection of the H5N1 viral strain in a wild goose ... flu infection to the sixth German state has been confirmed//. ... and is at significant risk of a dangerous epidemic. ... kilometres of where the bird was found as tests were ...
... the Duke University Medical Center have found that taking ... the chances of dying.// It was found that there ... patients who took such medications in spite of being ... degree of heart disease and severity of depression were ...
... involve a weakening of the muscles or ligaments that ... pelvic-floor disorders many of the activities are restricted. //In ... in severe cases, they may actually protrude outside the ... mild cases and surgery for more severe cases. It ...
... winter depression, of which 8 to 10 million are ... ,Current research indicates that the absence of sunlight ... as loss of energy, fatigue, lethargy, decreased activity, sadness, ... "winter depression" who go untreated can lose their jobs, ...
... College of Georgia said that genes that control blood pressure ... on more than 500 pairs of black and // white ... that changes in gene expression between ages 14 and 18 ... variation that occurred by age 18. The results were presented ...
Cached Medicine News:Health News:More Doctors Suspended As Strike Enters Seventh Day 2Health News:Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed 2Health News:'Winter Blues' Treated by Breakthrough Lighting Technology 2Health News:Genetic Reasons behind Change in One’s Blood Pressur 2
... designed for vascular labs already equipped ... Its primary use will be for ... cuff with air. Blood pressures ... - a proximal occluding cuff connected ...
... System is perfect for larger surgery suites that ... anesthetic agent. , ,The Integra II SP ... stance, has a larger work area. The ... in both the Integra I and II. ...
... Closures represent a needleless, intuitive ... of surgical incisions, excisions and ... film design provides unparalleled improvements ... visibility and cosmetic results, translating ...
The Next Generation in Operating Room Equipment and Management Solutions is here Today. NuBoom is a self-contained, pedestal-mounted boom that houses medical, audio and visual equipment....
Medicine Products: